Table 2. Adverse Events of Tacrolimus.
| Adverse event* | n (%) |
|---|---|
| Hypercholesterolemia | 36 (19.5) |
| Diarrhea | 30 (16.2) |
| BUN/Cr elevation | 28 (15.1) |
| Hair loss | 12 (6.5) |
| Hyperglycemia | 10 (5.4) |
| Hyperphosphatemia | 8 (4.3) |
| Hypophosphatemia | 8 (4.3) |
| Iron deficiency anemia | 7 (3.8) |
| Abdominal discomfort | 7 (3.8) |
| Tremor | 5 (2.7) |
| Paresthesia | 4 (2.2) |
| Eczema | 3 (1.6) |
| Headache | 3 (1.6) |
| High blood pressure | 3 (1.6) |
| Muscle cramp | 3 (1.6) |
| Thrombocytopenia | 3 (1.6) |
| Tinea pedis, oral fungal infection | 2 (1.1) |
| Chills | 2 (1.1) |
| Hyperkalemia | 2 (1.1) |
| Hypokalemia | 2 (1.1) |
| Dizziness | 1 (0.5) |
| Myalgia | 1 (0.5) |
| Visual disturbances | 1 (0.5) |
| Dysmenorrhea | 1 (0.5) |
| Oral ulcer | 1 (0.5) |
| Nail cracks | 1 (0.5) |
| Lower extremity edema | 1 (0.5) |
| Total number of adverse events observed | 185 (100.0) |
| Number of patients with adverse events | 68/160 (42.5) |
BUN/Cr, blood urea nitrogen/creatinine.
*Adverse events of tacrolimus were either reported by patients or detected in laboratory results. Multiple adverse events occurred concurrently in some patients.